Synthesis and A1 and A(2A) adenosine binding activity of some pyrano[2,3-c]pyrazol-4-ones

Farmaco

Volumn 53, Issue 3, 1998, Pages 189-196

  Colotta, Vittoria ^a   Catarzi, Daniela ^a   Varano, Flavia ^a   Melani, Fabrizio ^a   Filacchioni, Guido ^a   Cecchi, Lucia ^a   Trincavelli, Letizia ^b   Martini, Claudia ^b   Lucacchini, Antonio ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

A1 and A(2A) binding activity; Adenosine receptor ligands; Pyrano 2,3 c pyrazol 4 ones

Indexed keywords

1,4 DIHYDRO 1 PHENYL 3 METHYL 6 (3 AMINOPHENYL)PYRANO[2,3 C]PYRAZOL 4 ONE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; ADENOSINE A2A RECEPTOR; PYRAN DERIVATIVE; PYRAZOLE DERIVATIVE;

ARTICLE; DRUG SELECTIVITY; DRUG SYNTHESIS; LIGAND BINDING; RECEPTOR AFFINITY; SECOND MESSENGER; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; ANIMAL; CATTLE; CHEMICAL STRUCTURE; METABOLISM; SYNTHESIS;

ANIMALS; CATTLE; MOLECULAR STRUCTURE; PYRANS; PYRAZOLES; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1;

EID: 0032008556     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(98)00006-8     Document Type: Article

References (20)

1. [1] C.E. Muller, Pharm. Acta Helv. 68 (1993) 77-111.
2. [2] J. Coates, M.F. Gurden, C. Harris, I. Kennedy, M.J. Sheehan, P. Strong, Nucleotides Nucleosides 13 (1994) 1953-1976.
3. [3] K.A. Jacobson, F. Suzuki, Drug Dev. Res. 39 (1997) 289-300.
4. [4] C.E. Muller, B. Stein, Curr. Pharm. Des. 2 (1996) 501-530.
5. [5] J.W. Daly, J. Med. Chem. 25 (1982) 197-207.
6. [6] K.A. Jacobson, Neurotransmission 12 (1996) 1-6.
7. [7] C.E. Muller, Exp. Opin. Ther. Patents 7 (1997) 419-440.
8. [8] V. Colotta, L. Cecchi, D. Catarzi, F. Melani, G. Filacchioni, C. Martini, P. Tacchi, A. Lucacchini, Pharm. Pharmacol. Lett. 2 (1992) 74-76.
9. [9] V. Colotta, L. Cecchi, D. Catarzi, F. Melani, G. Filacchioni, C. Martini, P. Tacchi, A. Lucacchini, Receptors Channels 1 (1993) 111-119.
10. [10] V. Colotta, L. Cecchi, D. Catarzi, G. Filacchioni, C. Martini, P. Tacchi, A. Lucacchini, Eur. J. Med. Chem. 30 (1995) 133-139.
11. [11] D. Catarzi, L. Cecchi, V. Colotta, G. Filacchioni, C. Martini, P. Tacchi, A. Lucacchini, J. Med. Chem. 38 (1995) 1330-1336.
12. [12] L. Knorr, Justus Liebigs Ann. Chem. 238 (1887) 137-219.
13. [13] A. Michaelis, H. Behn, Chem. Ber. 33 (1900) 2595-2607.
14. [14] B. Chantegrel, A.-I. Nadi, S. Gelin, Synthesis (1983) 844-845.
15. [15] S. Gelin, B. Chantegrel, A.-I. Nadi, J. Org. Chem. 48 (1983) 4078-4082.
16. [16] E. Bellasio, A. Vigevani, G. Cristiani, E. Testa, Farmaco Ed. Sci. 25 (1970) 347-361.
17. [17] W.H. Perkin Jr., C. Bernhart, Chem. Ber. 17 (1884) 1522-1527
18. [18] B. Skytte Jensen, Acta Chem. Scand. 13 (1959) 1668-1670.
19. [19] O.H. Lowry, N.J. Rosenbrough, A.L. Farr, R.J. Randall, J. Biol. Chem. 193 (1951) 265-275.
20. [20] Y.C. Cheng, W.H. Prusoff, Biochem. Pharmacol. 22 (1973) 3099-3108.